BAX - Baxter International Inc.

NYSE - NYSE Delayed Price. Currency in USD

Baxter International Inc.

One Baxter Parkway
Deerfield, IL 60015
United States
224-948-2000
http://www.baxter.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees47,000

Key Executives

NameTitlePayExercisedYear Born
Mr. José E. AlmeidaChairman, Pres & CEO4.99MN/A1962
Mr. James K. SaccaroExec. VP & CFO1.79MN/A1973
Mr. Brik V. EyreSr. VP & Pres of Americas1.65MN/A1964
Mr. Giuseppe AccogliSr. VP & Pres of Global Bus.es2.62MN/A1971
Mr. Scott PleauSr. VP of OperationsN/AN/A1966
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Baxter International Inc. provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. The company also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.

Corporate Governance

Baxter International Inc.’s ISS Governance QualityScore as of April 1, 2018 is 4. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 5; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.